{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-064154","form_type":"8-K/A","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2023-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.191592+00:00","generated_at":"2026-06-14T16:10:15.008088+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"PowerUp Acquisition amends 8-K to correct redemption price to $284M ($10.55/share)","bullets":["Corrects redemption price from $283M ($10.51/share) to $284M ($10.55/share) for public shares tendered at May 2023 EGM.","26,946,271 public shares redeemed; approx $284M removed from trust account, leaving $19M and 1,803,729 shares outstanding.","No other changes to original filing; this is solely a price correction."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-064154","json":"https://secwatch.observer/filing/0001104659-23-064154.json","markdown":"https://secwatch.observer/filing/0001104659-23-064154.md","text":"https://secwatch.observer/filing/0001104659-23-064154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000110465923064154/0001104659-23-064154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000110465923064154/tm2316911d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T16:10:15.008088+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}